glp-1 and gip receptor agonist Major physiological roles of GIP. Tirzepatide is acting as an GLP1-GIP receptor co-agonists: a promising

Despite variations in data sources, adjustment techniques, risk estimates, and comparator drugs, these findings collectively suggest that GLP-1RAs are not associated with an altered risk of depression

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

Dosing protocols and administration Both mazdutide and retatrutide are administered as once-weekly subcutaneous injections

GLP-1 agonists come in pens that enable gradual dose increases

No changes in the atherosclerotic lesions size were detected, however, plaque vulnerability was reduced